Insights

Strategic fit Target non-viral, precision genetic medicine delivery capability to address genetic diseases with delivery challenges, aligning with Code Bio’s 3DNA platform to potentially reduce dose-related toxicity and off-target effects for potential collaborations or licensing.

DMD focus Prioritize engagement around Duchenne Muscular Dystrophy programs where Code Bio has its most advanced research, exploring partnerships, joint development, or funding avenues to accelerate translational efforts and clinical progression.

Clinical partnerships Leverage existing collaboration history with Takeda and strong VC/institutional backing to propose co-development or strategic investment conversations, offering access to Code Bio’s proprietary delivery platform for rare disease indications.

Expansion opportunities Position opportunities in lungs, pancreas, and liver programs for biotech and pharma partners seeking targeted genetic therapies, suggesting BD outreach around cross-organ delivery capabilities and pipeline expansion.

Scale and capabilities Highlight the potential for accelerated development through Code Bio’s fresh leadership hires in technical and research translation roles, proposing services, value-based partnerships, or manufacturing collaboration to support clinical-stage programs.

Code Biotherapeutics Tech Stack

Code Biotherapeutics uses 8 technology products and services including Amazon Web Services, Wix, Wix eCommerce, and more. Explore Code Biotherapeutics's tech stack below.

Amazon Web Services

Cloud Hosting

Wix

Content Management System

Wix eCommerce

E-commerce

Microsoft 365

Google Cloud

Infrastructure As A Service

Sentry

Issue Trackers

Microsoft Teams

Team Collaboration

Vimeo

Video Players

Code Biotherapeutics Email Formats	Example	Percentage
FLast@codebiotx.com	JDoe@codebiotx.com	97%
FL@codebiotx.com	JD@codebiotx.com	1%
FirstLast@codebiotx.com	JohnDoe@codebiotx.com	2%

Code Biotherapeutics Email Formats

Example

Percentage

FLast@codebiotx.com

JDoe@codebiotx.com

97%

FL@codebiotx.com

JD@codebiotx.com

FirstLast@codebiotx.com

JohnDoe@codebiotx.com

Frequently Asked Questions

What is Code Biotherapeutics's official website and social media links?

Code Biotherapeutics's official website is codebiotx.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Code Biotherapeutics generate?

As of August 2026, Code Biotherapeutics's annual revenue is estimated to be $10M - $25M.

What is Code Biotherapeutics's SIC code and NAICS code?

Code Biotherapeutics's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Code Biotherapeutics have currently?

As of August 2026, Code Biotherapeutics has approximately 23 employees across 1 continents, including North America. Key team members include Chief Technical Officer: A. T., Development Scientist: K. D. and Research Scientist | Biochemistry And Molecular Biology: J. A. Explore Code Biotherapeutics's employee directory with LeadIQ.

What industry does Code Biotherapeutics belong to?

Code Biotherapeutics operates in the Biotechnology Research industry.

What technology does Code Biotherapeutics use?

Code Biotherapeutics's tech stack includes Amazon Web Services, Wix, Wix eCommerce, Microsoft 365, Google Cloud, Sentry, Microsoft Teams and Vimeo.

What is Code Biotherapeutics's email format?

Code Biotherapeutics's email format typically follows the pattern of FLast@codebiotx.com. Find more Code Biotherapeutics email formats with LeadIQ.

How much funding has Code Biotherapeutics raised to date?

As of August 2026, Code Biotherapeutics has raised $85M in funding. The last funding round occurred on Jun 07, 2022 for $75M.

When was Code Biotherapeutics founded?

Code Biotherapeutics was founded in 2020.

Code Biotherapeutics

Q: What is Code Biotherapeutics's official website and social media links?

Code Biotherapeutics's official website is codebiotx.com. Code Biotherapeutics has social profiles on LinkedIn.

Q: How many employees does Code Biotherapeutics have currently?

Code Biotherapeutics has approximately 23 employees.

Q: What technology does Code Biotherapeutics use?

Code Biotherapeutics's tech stack includes Cart Functionality, JMP Statistical Discovery, Microsoft Office, Google Analytics Enhanced eCommerce, Polyfill.

Q: What is Code Biotherapeutics's NAICS code?

Code Biotherapeutics's NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Biotechnology ResearchPennsylvania, United States11-50 Employees

Code Biotherapeutics is a small to mid-sized biotechnology company based in Hatfield, Pennsylvania, pursuing precision genetic medicines. It has developed a proprietary non-viral DNA delivery platform designed to overcome common obstacles in gene therapy, such as safety concerns, dosing constraints, off-target effects, immune responses, and vector manufacturing complexity. The company’s internal pipeline focuses on multiple genetic diseases, with its most advanced work in Duchenne muscular dystrophy.
It also conducts research programs aimed at diseases affecting the lungs, pancreas, and liver. A notable development in its history is a collaboration with Takeda to apply its delivery approach to rare disease programs.

Insights

Similar companies to Code Biotherapeutics